Stryker Corp
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Instruments by Quarter
Instruments (Current Q1-2026 Basis incl. Neuro Cranial) — Worldwide Net Sales ($M) ($M)
Stryker Instruments: $996M in Q3 2026, up 5.0% from a year earlier.
Where the Q3 2026 figure comes from
Recast basis effective Q1 2026 (includes Neuro Cranial & Interventional Spine; excludes Orthopaedic Instruments & Enabling Technologies moved to Ortho Tech).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up instruments
- Instruments (Current Q1-2026 Basis incl. Neuro Cranial) — Worldwide Constant Currency Sales Growth YoY (%)5.2% · Q3 2026
- Instruments (Current Q1-2026 Basis incl. Neuro Cranial) — Worldwide Reported Sales Growth YoY (%)5.1% · Q3 2026
- Instruments (Current Q1-2026 Basis incl. Neuro Cranial) — U.S. Net Sales ($M)835 · Q3 2026
- Instruments (Current Q1-2026 Basis incl. Neuro Cranial) — International Net Sales ($M)161 · Q3 2026
- Standalone Sub-Portfolio: Neuro Cranial — Worldwide Net Sales ($M)670 · Q3 2026
- Instruments (Legacy Pre-2026 Basis, through FY2025Q4) — Worldwide Net Sales ($M)925 · Q4 2025
Cite this data
StockData. (2026). Stryker Instruments ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-inst-ww-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.